Home > > > > > Report Detail

Global Acute Myeloid Leukemia Therapeutics Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 12-Jul-2021
No. of pages: 97
Inquire Before Buying

Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90% of acute myeloid leukemia is diagnosed in middle age. Incidence rate of acute myeloid leukemia is high in men and women over 50 years.

Geographically, acute myeloid leukemia therapeutics market is divided into North America, Europe, Asia Pacific, Latin America, and MEA. As of 2014, North America held substantial share of the acute myeloid leukemia therapeutics market owing to prominent growth factors including rising incidences of acute myeloid leukemia and increasing geriatric population. Furthermore, advanced healthcare infrastructure, rising need of targeted therapies, huge investment in the development of pipeline drugs, and awareness amongst the population base induced market growth in this region. Asia Pacific is expected to be the fastest growing region over the forecast period owing to growth factors such as rising investments, rising disposable incomes, increasing cancer awareness, and improving healthcare infrastructure. Additionally, increasing inclination towards therapies such as targeted therapies resulting in low collateral damage and stronger efficacy is also anticipated to propel the demand for the acute myeloid leukemia therapeutics market in this region.

Market Analysis and Insights: Global Acute Myeloid Leukemia Therapeutics Market

The global Acute Myeloid Leukemia Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Myeloid Leukemia Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Myeloid Leukemia Therapeutics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Myeloid Leukemia Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Myeloid Leukemia Therapeutics market.

Global Acute Myeloid Leukemia Therapeutics Scope and Market Size

Acute Myeloid Leukemia Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Myeloid Leukemia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Pipeline Drugs

- Chemotherapy Drugs

- Chemotherapy Regimens

Segment by Application

- Hospitals

- Clinics

- Home Care

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Ambit Biosciences Corporation

- Genzyme Corporation Celgene Corporation

- Clavis Pharma ASA

- Sunesis Pharmaceuticals

- Cephalon

- Bristol-Myers Squibb

- Novartis International AG

- GlaxoSmithKline

Global Acute Myeloid Leukemia Therapeutics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Myeloid Leukemia Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pipeline Drugs
1.2.3 Chemotherapy Drugs
1.2.4 Chemotherapy Regimens
1.3 Market by Application
1.3.1 Global Acute Myeloid Leukemia Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Home Care
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Acute Myeloid Leukemia Therapeutics Market Perspective (2016-2027)
2.2 Acute Myeloid Leukemia Therapeutics Growth Trends by Regions
2.2.1 Acute Myeloid Leukemia Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Myeloid Leukemia Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Acute Myeloid Leukemia Therapeutics Industry Dynamic
2.3.1 Acute Myeloid Leukemia Therapeutics Market Trends
2.3.2 Acute Myeloid Leukemia Therapeutics Market Drivers
2.3.3 Acute Myeloid Leukemia Therapeutics Market Challenges
2.3.4 Acute Myeloid Leukemia Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Myeloid Leukemia Therapeutics Players by Revenue
3.1.1 Global Top Acute Myeloid Leukemia Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Acute Myeloid Leukemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Myeloid Leukemia Therapeutics Revenue
3.4 Global Acute Myeloid Leukemia Therapeutics Market Concentration Ratio
3.4.1 Global Acute Myeloid Leukemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Myeloid Leukemia Therapeutics Revenue in 2020
3.5 Acute Myeloid Leukemia Therapeutics Key Players Head office and Area Served
3.6 Key Players Acute Myeloid Leukemia Therapeutics Product Solution and Service
3.7 Date of Enter into Acute Myeloid Leukemia Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Myeloid Leukemia Therapeutics Breakdown Data by Type
4.1 Global Acute Myeloid Leukemia Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Type (2022-2027)
5 Acute Myeloid Leukemia Therapeutics Breakdown Data by Application
5.1 Global Acute Myeloid Leukemia Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Acute Myeloid Leukemia Therapeutics Market Size (2016-2027)
6.2 North America Acute Myeloid Leukemia Therapeutics Market Size by Type
6.2.1 North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2027)
6.3 North America Acute Myeloid Leukemia Therapeutics Market Size by Application
6.3.1 North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2027)
6.4 North America Acute Myeloid Leukemia Therapeutics Market Size by Country
6.4.1 North America Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Acute Myeloid Leukemia Therapeutics Market Size (2016-2027)
7.2 Europe Acute Myeloid Leukemia Therapeutics Market Size by Type
7.2.1 Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2027)
7.3 Europe Acute Myeloid Leukemia Therapeutics Market Size by Application
7.3.1 Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2027)
7.4 Europe Acute Myeloid Leukemia Therapeutics Market Size by Country
7.4.1 Europe Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Type
8.2.1 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Application
8.3.1 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Region
8.4.1 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Acute Myeloid Leukemia Therapeutics Market Size (2016-2027)
9.2 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type
9.2.1 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application
9.3.1 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country
9.4.1 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Type
10.2.1 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Application
10.3.1 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Country
10.4.1 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Ambit Biosciences Corporation
11.1.1 Ambit Biosciences Corporation Company Details
11.1.2 Ambit Biosciences Corporation Business Overview
11.1.3 Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Introduction
11.1.4 Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
11.1.5 Ambit Biosciences Corporation Recent Development
11.2 Genzyme Corporation Celgene Corporation
11.2.1 Genzyme Corporation Celgene Corporation Company Details
11.2.2 Genzyme Corporation Celgene Corporation Business Overview
11.2.3 Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Introduction
11.2.4 Genzyme Corporation Celgene Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
11.2.5 Genzyme Corporation Celgene Corporation Recent Development
11.3 Clavis Pharma ASA
11.3.1 Clavis Pharma ASA Company Details
11.3.2 Clavis Pharma ASA Business Overview
11.3.3 Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Introduction
11.3.4 Clavis Pharma ASA Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
11.3.5 Clavis Pharma ASA Recent Development
11.4 Sunesis Pharmaceuticals
11.4.1 Sunesis Pharmaceuticals Company Details
11.4.2 Sunesis Pharmaceuticals Business Overview
11.4.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Introduction
11.4.4 Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
11.4.5 Sunesis Pharmaceuticals Recent Development
11.5 Cephalon
11.5.1 Cephalon Company Details
11.5.2 Cephalon Business Overview
11.5.3 Cephalon Acute Myeloid Leukemia Therapeutics Introduction
11.5.4 Cephalon Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
11.5.5 Cephalon Recent Development
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Details
11.6.2 Bristol-Myers Squibb Business Overview
11.6.3 Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Introduction
11.6.4 Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
11.6.5 Bristol-Myers Squibb Recent Development
11.7 Novartis International AG
11.7.1 Novartis International AG Company Details
11.7.2 Novartis International AG Business Overview
11.7.3 Novartis International AG Acute Myeloid Leukemia Therapeutics Introduction
11.7.4 Novartis International AG Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
11.7.5 Novartis International AG Recent Development
11.8 GlaxoSmithKline
11.8.1 GlaxoSmithKline Company Details
11.8.2 GlaxoSmithKline Business Overview
11.8.3 GlaxoSmithKline Acute Myeloid Leukemia Therapeutics Introduction
11.8.4 GlaxoSmithKline Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
11.8.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Acute Myeloid Leukemia Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pipeline Drugs
Table 3. Key Players of Chemotherapy Drugs
Table 4. Key Players of Chemotherapy Regimens
Table 5. Global Acute Myeloid Leukemia Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Acute Myeloid Leukemia Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Acute Myeloid Leukemia Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Acute Myeloid Leukemia Therapeutics Market Share by Regions (2016-2021)
Table 9. Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Acute Myeloid Leukemia Therapeutics Market Share by Regions (2022-2027)
Table 11. Acute Myeloid Leukemia Therapeutics Market Trends
Table 12. Acute Myeloid Leukemia Therapeutics Market Drivers
Table 13. Acute Myeloid Leukemia Therapeutics Market Challenges
Table 14. Acute Myeloid Leukemia Therapeutics Market Restraints
Table 15. Global Acute Myeloid Leukemia Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Acute Myeloid Leukemia Therapeutics Market Share by Players (2016-2021)
Table 17. Global Top Acute Myeloid Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Myeloid Leukemia Therapeutics as of 2020)
Table 18. Ranking of Global Top Acute Myeloid Leukemia Therapeutics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Acute Myeloid Leukemia Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Acute Myeloid Leukemia Therapeutics Product Solution and Service
Table 22. Date of Enter into Acute Myeloid Leukemia Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Type (2016-2021)
Table 26. Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Acute Myeloid Leukemia Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Application (2016-2021)
Table 30. Global Acute Myeloid Leukemia Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Ambit Biosciences Corporation Company Details
Table 63. Ambit Biosciences Corporation Business Overview
Table 64. Ambit Biosciences Corporation Acute Myeloid Leukemia Therapeutics Product
Table 65. Ambit Biosciences Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 66. Ambit Biosciences Corporation Recent Development
Table 67. Genzyme Corporation Celgene Corporation Company Details
Table 68. Genzyme Corporation Celgene Corporation Business Overview
Table 69. Genzyme Corporation Celgene Corporation Acute Myeloid Leukemia Therapeutics Product
Table 70. Genzyme Corporation Celgene Corporation Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 71. Genzyme Corporation Celgene Corporation Recent Development
Table 72. Clavis Pharma ASA Company Details
Table 73. Clavis Pharma ASA Business Overview
Table 74. Clavis Pharma ASA Acute Myeloid Leukemia Therapeutics Product
Table 75. Clavis Pharma ASA Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 76. Clavis Pharma ASA Recent Development
Table 77. Sunesis Pharmaceuticals Company Details
Table 78. Sunesis Pharmaceuticals Business Overview
Table 79. Sunesis Pharmaceuticals Acute Myeloid Leukemia Therapeutics Product
Table 80. Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 81. Sunesis Pharmaceuticals Recent Development
Table 82. Cephalon Company Details
Table 83. Cephalon Business Overview
Table 84. Cephalon Acute Myeloid Leukemia Therapeutics Product
Table 85. Cephalon Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 86. Cephalon Recent Development
Table 87. Bristol-Myers Squibb Company Details
Table 88. Bristol-Myers Squibb Business Overview
Table 89. Bristol-Myers Squibb Acute Myeloid Leukemia Therapeutics Product
Table 90. Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 91. Bristol-Myers Squibb Recent Development
Table 92. Novartis International AG Company Details
Table 93. Novartis International AG Business Overview
Table 94. Novartis International AG Acute Myeloid Leukemia Therapeutics Product
Table 95. Novartis International AG Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 96. Novartis International AG Recent Development
Table 97. GlaxoSmithKline Company Details
Table 98. GlaxoSmithKline Business Overview
Table 99. GlaxoSmithKline Revenue in Acute Myeloid Leukemia Therapeutics Business (2016-2021) & (US$ Million)
Table 100. GlaxoSmithKline Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Myeloid Leukemia Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Pipeline Drugs Features
Figure 3. Chemotherapy Drugs Features
Figure 4. Chemotherapy Regimens Features
Figure 5. Global Acute Myeloid Leukemia Therapeutics Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Home Care Case Studies
Figure 9. Acute Myeloid Leukemia Therapeutics Report Years Considered
Figure 10. Global Acute Myeloid Leukemia Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Acute Myeloid Leukemia Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Acute Myeloid Leukemia Therapeutics Market Share by Regions: 2020 VS 2027
Figure 13. Global Acute Myeloid Leukemia Therapeutics Market Share by Regions (2022-2027)
Figure 14. Global Acute Myeloid Leukemia Therapeutics Market Share by Players in 2020
Figure 15. Global Top Acute Myeloid Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Myeloid Leukemia Therapeutics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Acute Myeloid Leukemia Therapeutics Revenue in 2020
Figure 17. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Type (2016-2021)
Figure 18. Global Acute Myeloid Leukemia Therapeutics Revenue Market Share by Type (2022-2027)
Figure 19. North America Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Acute Myeloid Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 21. North America Acute Myeloid Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 22. North America Acute Myeloid Leukemia Therapeutics Market Share by Country (2016-2027)
Figure 23. United States Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Acute Myeloid Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 27. Europe Acute Myeloid Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 28. Europe Acute Myeloid Leukemia Therapeutics Market Share by Country (2016-2027)
Figure 29. Germany Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Acute Myeloid Leukemia Therapeutics Market Share by Region (2016-2027)
Figure 39. China Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Acute Myeloid Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 47. Latin America Acute Myeloid Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 48. Latin America Acute Myeloid Leukemia Therapeutics Market Share by Country (2016-2027)
Figure 49. Mexico Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Acute Myeloid Leukemia Therapeutics Market Share by Country (2016-2027)
Figure 55. Turkey Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Acute Myeloid Leukemia Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Ambit Biosciences Corporation Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
Figure 59. Genzyme Corporation Celgene Corporation Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
Figure 60. Clavis Pharma ASA Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
Figure 61. Sunesis Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
Figure 62. Cephalon Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
Figure 64. Novartis International AG Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
Figure 65. GlaxoSmithKline Revenue Growth Rate in Acute Myeloid Leukemia Therapeutics Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
  • Global Cancer Immunomodulator Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Cancer Immunomodulator market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cancer Immunomodulator is estimated to increase from $ million in 2023 to reach $ ......
  • Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market size was valued at US$ 14070 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) is forecast to a readjusted size of US$ 57240 million by 2030 with a CAGR of 22.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells (CTCs) and Canc......
  • Global Circulating Tumor Cells Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Circulating Tumor Cells market size was valued at US$ 1550.1 million in 2023. With growing demand in downstream market, the Circulating Tumor Cells is forecast to a readjusted size of US$ 5942.1 million by 2030 with a CAGR of 21.2% during review period. The research report highlights the growth potential of the global Circulating Tumor Cells market. Circulating Tumor Cells are expected to show stable growth in the future mark......
  • Global Circulating Tumor Cells Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 125
    According to our (Global Info Research) latest study, the global Circulating Tumor Cells market size was valued at USD 1630.5 million in 2023 and is forecast to a readjusted size of USD 5681.6 million by 2030 with a CAGR of 19.5% during review period. Circulating tumor cells are cancer cells that have detached from the tumor and are found at extremely low levels in the bloodstream. The value of capturing and counting CTCs is evolving as more research data is gathered about the utility of......
  • Small Molecule Targeted Cancer Therapy - Global Market Insights and Sales Trends 2024
    Published: 27-Dec-2023        Price: US 3350 Onwards        Pages: 112
    This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking By Company; 3) comprehensive presentation of the global market for Small Molecule Targeted Cancer Therapy, with......
  • Global Cancer Gene Therapy Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 101
    Market Overview of Global Cancer Gene Therapy market: According to our latest research, the global Cancer Gene Therapy market looks promising in the next 5 years. As of 2022, the global Cancer Gene Therapy market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cancer Gene Th......
  • T-Cell Immunotherapy - Global Market Insights and Sales Trends 2024
    Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 85
    CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively. The global T-Cell Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of T-Cell Immunotherapy in various end use industries. The expanding demands from the Stomach ......
  • Global Kaposi Sarcoma Market Status and Outlook 2023-2028
    Published: 22-Dec-2023        Price: US 3160 Onwards        Pages: 107
    Kaposi's sarcoma is a type of cancer that forms in the lining of blood and lymph vessels. The tumors (lesions) of Kaposi's sarcoma typically appear as painless purplish spots on the legs, feet or face. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking a......
  • Global Cancer Immunomodulator Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Cancer Immunomodulator market: According to our latest research, the global Cancer Immunomodulator market looks promising in the next 5 years. As of 2022, the global Cancer Immunomodulator market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Cance......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs